v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid in Capital
Accumulated Other Comprehensive Income/(Loss)
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2024   33,893,409,000      
Beginning balance at Dec. 31, 2024 $ 2,503,405 $ 34 $ 12,305,250 $ 1,451 $ (9,803,330)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (106,213)       (106,213)
Stock-based compensation expense 16,261   16,261    
Other comprehensive (loss) income 215     215  
Release of restricted stock units (in shares)   1,403,449,000      
Release of restricted stock units 0 $ 1 (1)    
Ending balance (in shares) at Mar. 31, 2025   35,296,858,000      
Ending balance at Mar. 31, 2025 2,413,668 $ 35 12,321,510 1,666 (9,909,543)
Beginning balance (in shares) at Dec. 31, 2024   33,893,409,000      
Beginning balance at Dec. 31, 2024 2,503,405 $ 34 12,305,250 1,451 (9,803,330)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (220,198)        
Ending balance (in shares) at Jun. 30, 2025   36,047,799,000      
Ending balance at Jun. 30, 2025 2,314,643 $ 36 12,335,832 2,303 (10,023,528)
Beginning balance (in shares) at Mar. 31, 2025   35,296,858,000      
Beginning balance at Mar. 31, 2025 2,413,668 $ 35 12,321,510 1,666 (9,909,543)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (113,985)       (113,985)
Stock-based compensation expense 14,323   14,323    
Other comprehensive (loss) income 637     637  
Release of restricted stock units (in shares)   750,941,000      
Release of restricted stock units 0 $ 1 (1)    
Ending balance (in shares) at Jun. 30, 2025   36,047,799,000      
Ending balance at Jun. 30, 2025 $ 2,314,643 $ 36 12,335,832 2,303 (10,023,528)
Beginning balance (in shares) at Dec. 31, 2025 40,331,360 40,331,360,000      
Beginning balance at Dec. 31, 2025 $ 2,577,862 $ 40 12,786,848 2,655 (10,211,681)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (93,187)       (93,187)
Stock-based compensation expense 16,793   16,793    
Other comprehensive (loss) income (782)     (782)  
Release of restricted stock units (in shares)   802,859,000      
Release of restricted stock units 0 $ 1 (1)    
Ending balance (in shares) at Mar. 31, 2026   41,134,219,000      
Ending balance at Mar. 31, 2026 $ 2,500,686 $ 41 12,803,640 1,873 (10,304,868)
Beginning balance (in shares) at Dec. 31, 2025 40,331,360 40,331,360,000      
Beginning balance at Dec. 31, 2025 $ 2,577,862 $ 40 12,786,848 2,655 (10,211,681)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss $ (203,434)        
Ending balance (in shares) at Jun. 30, 2026 44,666,234 44,666,234,000      
Ending balance at Jun. 30, 2026 $ 2,542,654 $ 45 12,955,884 1,840 (10,415,115)
Beginning balance (in shares) at Mar. 31, 2026   41,134,219,000      
Beginning balance at Mar. 31, 2026 2,500,686 $ 41 12,803,640 1,873 (10,304,868)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (110,247)       (110,247)
Stock-based compensation expense 19,557   19,557    
Issuance of common stock under ESPP (in shares)   87,446,000      
Issuance of common stock under ESPP 4,593   4,593    
Other comprehensive (loss) income (33)     (33)  
Release of restricted stock units (in shares)   1,874,261,000      
Release of restricted stock units 0 $ 2 (2)    
Issuance of common stock in connection with the Samsung SPA, net of issuance costs (in shares)   1,570,308,000      
Issuance of common stock and recognition of the Samsung Stock Purchase Agreement, including the deferred asset, net of tax benefit and issuance costs $ 128,098 $ 2 128,096    
Ending balance (in shares) at Jun. 30, 2026 44,666,234 44,666,234,000      
Ending balance at Jun. 30, 2026 $ 2,542,654 $ 45 $ 12,955,884 $ 1,840 $ (10,415,115)